NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE YEARS ENDED DECEMBER 31, 2020 AND 2019
NOTE
1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
History
and Organization
Generation
Alpha, Inc. (the “Company”) was originally incorporated under the laws of the State of Nevada on March 2, 2007 as
Cinjet, Inc. (“Cinjet”). Effective September 1, 2015, Cinjet changed its corporate name to Solis Tek Inc. (“Solis
Tek”). Effective September 25, 2018, Solis Tek changed its corporate name to Generation Alpha, Inc. Effective September
25, 2018, Generation Alpha, Inc. (f/k/a Solis Tek Inc.) (the “Company”) entered into an agreement and plan of merger
(the “Merger Agreement”), whereby a wholly-owned subsidiary of the Company (the “Merger Sub”) was merged
into the Company (the “Merger”). Upon consummation of the Merger, the separate existence of Merger Sub ceased. On
June 23, 2015, the Company entered into an Agreement of Merger and Plan of Reorganization (the “Agreement”) with Solis
Tek Inc., a California corporation (“STI”), and CJA Acquisition Corp., a California corporation and a wholly owned
subsidiary of the Company (“Merger Sub”), providing for the merger of Merger Sub with and into STI (the “Merger”),
with STI surviving the Merger as a wholly-owned subsidiary of the Company. The Merger was accounted for as a recapitalization
of the Company with STI being deemed the accounting acquirer.
Overview
of Business
The
Company is a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products
and solutions to commercial and retail cannabis growers in both the medical and adult use recreational space in legal markets
across the U.S. The Company’s lighting and nutrient customers include retail stores, distributors and commercial growers
in the United States and abroad.
COVID-19
Considerations
During
the year ended December 31, 2020, the COVID-19 pandemic did not have a material net impact on our operating results. Although
there were delays in product manufacturing and delivery from China during parts of 2020 as a result of COVID-19, manufacturing
and shipping did resume later in 2020, resulting in little overall impact on operating results. We do continue to see longer lead
times from product ordering to delivery. In the future, the pandemic may cause reduced demand for our products if, for example,
the pandemic results in a recessionary economic environment which negatively effects the consumers who purchase our products.
The Company has not observed any material impairments of its assets or a significant change in the fair value of its assets due
to the COVID-19 pandemic.
Our
ability to operate without significant negative operational impact from the COVID-19 pandemic will in part depend on our ability
to protect our employees and our supply chain. The Company has endeavored to follow the recommended actions of government and
health authorities to protect our employees. Since the onset of the COVID-19 pandemic, we maintained the consistency of our operations.
However, the uncertainty resulting from the pandemic could result in an unforeseen disruption to our workforce and supply chain
(for example an inability of a key supplier or transportation supplier to source and transport materials) that could negatively
impact our operations.
Going
Concern
The
accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization
of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying
consolidated financial statements, during the year ended December 31, 2020, the Company incurred a net loss of $571,000 and used
cash in operations of $499,000 and had a shareholders’ deficit of $8,736,000 as of December 31, 2020. In addition, $2,565,000
of notes payable to related parties, $531,000 of accrued interest to related parties, and $816,000 of contract obligations are
past due. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year
after the date of the financial statements being issued. The ability of the Company to continue as a going concern is dependent
upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include
any adjustments that might be necessary if the Company is unable to continue as a going concern.
At
December 31, 2020, the Company had cash on hand in the amount of $372,000. Management estimates that the current funds on hand
will be sufficient to continue operations through September 30, 2021. The continuation of the Company as a going concern is dependent
upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash
flow. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are
satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on
our operations, in the case of debt financing or cause substantial dilution for our stockholders, in case or equity financing.
Basis
of Consolidation
The
consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: STI; Solis Tek East,
Corporation (“STE”), an entity incorporated under the laws of the State of New Jersey, Zelda Horticulture, Inc. (“Zelda”),
an entity incorporated under the laws of the State of California, and YLK Partners NV, LLC (“YLK”), Generation Alpha
Brands, Inc., Trilogy Dispensaries, Inc., Extracting Point, LLC (“Extracting Point”), and GrowPro Solutions, Inc.,
all entities formed under the laws of Nevada. Intercompany transactions and balances have been eliminated in consolidation.
Use
of Estimates
The
preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent
assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period.
Significant estimates are used in valuing our allowances for doubtful accounts, reserves for inventory obsolescence, valuing derivative
liabilities, valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual
results could differ from these estimates.
Revenue
Recognition
The
Company recognizes revenue in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification
(“ASC”) 606, Revenue from Contracts with Customers (“ASC 606”). This standard provides authoritative
guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted
accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of
promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled
in the exchange for those goods or services.
Revenue
is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects
the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales
transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices
to separate performance obligations, if applicable. Revenue and cost of sales are recognized once products are delivered to the
customer’s control and performance obligations are satisfied.
All
products sold by the Company are distinct individual products and consist of advanced energy efficient indoor horticulture lighting,
plant nutrient products, and ancillary equipment. The products are offered for sale as finished goods only, and there are no performance
obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives
or discounts that could cause revenue to be allocated or adjusted over time.
The
Company does not offer a general right of return on any of its sales and considers all sales as final. The Company generally provides
a three-year warranty on its ballasts. However, the Company does not maintain a warranty reserve as the Company is able to chargeback
its vendors for all warranty claims. As of December 31, 2020, and 2019, the Company recorded reserves for returned product in
the amounts of $0 and $60,000, respectively, which reduced the accounts receivable balances as of those periods.
In
the following table, revenue is disaggregated by major product line for the year ended 2020:
Sales
Channels
|
|
Lighting
|
|
|
Plant
Nutrients and Fertilizers
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
Hydroponic resellers/retail
|
|
$
|
433,000
|
|
|
$
|
827,000
|
|
|
$
|
1,260,000
|
|
Direct to consumer/online
|
|
|
22,000
|
|
|
|
-
|
|
|
|
22,000
|
|
Total
|
|
$
|
455,000
|
|
|
$
|
827,000
|
|
|
$
|
1,282,000
|
|
In
the following table, revenue is disaggregated by major product line for the year ended 2019:
Sales
Channels
|
|
Lighting
|
|
|
Plant
Nutrients and Fertilizers
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
Hydroponic resellers/retail
|
|
$
|
1,411,000
|
|
|
$
|
496,000
|
|
|
$
|
1,907,000
|
|
Direct to consumer/online
|
|
|
58,000
|
|
|
|
-
|
|
|
|
58,000
|
|
Total
|
|
$
|
1,469,000
|
|
|
$
|
496,000
|
|
|
$
|
1,965,000
|
|
Accounts
Receivable
Accounts
receivable are recorded net of an allowance for expected losses. The Company evaluates the collectability of its trade accounts
receivable based on a number of factors. In circumstances where the Company becomes aware of a specific customer’s inability
to meet its financial obligations to the Company, a specific reserve for bad debts is estimated and recorded, which reduces the
recognized receivable to the estimated amount the Company believes will ultimately be collected. In addition to specific customer
identification of potential bad debts, bad debt charges are recorded based on the Company’s historical losses and an overall
assessment of past due trade accounts receivable outstanding.
The
allowance for doubtful accounts and returns is established through a provision reducing the carrying value of receivables. At
December 31, 2020 and 2019, the allowance for doubtful accounts was $12,000 and $52,000, respectively.
Inventories
Inventories
are stated at the lower of cost or net realizable value. Cost is computed on a first-in, first-out basis. The Company’s
inventories consist almost entirely of finished goods as of December 31, 2020 and 2019.
The
Company provides inventory reserves based on excess and obsolete inventories determined primarily by future demand forecasts.
The write down amount is measured as the difference between the cost of the inventory and net realizable value based on upon assumptions
about future demand and charged to the provision for inventory write down, which is a component of cost of sales. At the point
of the loss recognition, a new, lower cost basis for that inventory is established, and subsequent changes in facts and circumstances
do not result in the restoration or increase in that newly established cost basis. At December 31, 2020 and 2019, the reserve
for excess and obsolete inventory was $30,000 and $125,000, respectively.
Property
and Equipment
Property
and equipment are carried at cost less accumulated depreciation and amortization. Depreciation is calculated using the straight-line
method over the estimated useful lives of the assets. The Company has determined the estimated useful lives of its property and
equipment, as follows:
Machinery
and equipment
|
5
years
|
Computer
equipment
|
3
years
|
Furniture
and fixtures
|
7
years
|
Maintenance
and repairs are charged to expense as incurred. The cost and accumulated depreciation of assets sold or otherwise disposed of
are removed from the related accounts and the resulting gain or loss is reflected in the statements of operations.
Management
assesses the carrying value of property and equipment whenever events or changes in circumstances indicate that the carrying value
may not be recoverable. If there is an indication of impairment, management prepares an estimate of future cash flows expected
to result from the use of the asset and its eventual disposition. If these cash flows are less than the carrying amount of the
asset, an impairment loss is recognized to write down the asset to its estimated fair value. The Company did not record an impairment
loss for the years ended December 31, 2020 and 2019.
Intangible
Assets
The
Company accounts for intangible assets in accordance with the authoritative guidance issued by the FASB. Intangibles are valued
at their fair market value and are amortized taking into account the character of the acquired intangible asset and the expected
period of benefit. The Company evaluates intangible assets for impairment, at a minimum, on an annual basis and whenever events
or changes in circumstances indicate that the carrying value may not be recoverable from its estimated undiscounted future cash
flows. Recoverability of intangible assets is measured by comparing their net book value to the related projected undiscounted
cash flows from these assets, considering a number of factors, including past operating results, budgets, economic projections,
market trends and product development cycles. If the net book value of the asset exceeds the related undiscounted cash flows,
the asset is considered impaired, and a second test is performed to measure the amount of impairment loss.
At
December 31, 2018, the Company had intangible assets of $1,302,000 that consisted of a license right. In June 2019, and based
on management’s assessment, it was determined that the intangible asset was impaired, and an impairment charge was recorded
for $1,139,000 during the year ended December 31, 2019.
Leases
Prior
to January 1, 2019, the Company accounted for leases under ASC 840, Accounting for Leases. Effective January 1, 2019, the Company
adopted the guidance of ASC 842, Leases (“ASC 842”), which requires an entity to recognize a right of use (“ROU”)
asset and a lease liability for virtually all leases. The Company adopted ASC 842 using a modified retrospective approach. The
adoption of ASC 842 on January 1, 2019 resulted in the recognition of operating lease ROU assets and lease liabilities for operating
leases of $645,000. There was no cumulative-effect adjustment to accumulated deficit.
Income
Taxes
Income
tax expense is based on pretax financial accounting income. Deferred tax assets and liabilities are recognized for the expected
tax consequences of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation
allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company has
recorded a valuation allowance against its deferred tax assets as of December 31, 2020 and 2019.
The
Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions.
The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that
it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation
processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50 percent likely of
being realized upon settlement. The Company classifies the liability for unrecognized tax benefits as current to the extent that
the Company anticipates payment (or receipt) of cash within one year. Interest and penalties related to uncertain tax positions
are recognized in the provision for income taxes.
Derivative
Financial Instruments
The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported
in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities
are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument
could be required within 12 months of the balance sheet date.
Research
and Development
Research
and development costs are expensed in the period incurred. The costs primarily consist of personnel and supplies.
Shipping
and Handling Costs
The
Company’s shipping and handling costs relating to inbound freight are reported as cost of goods sold in the consolidated
Statements of Operations, while shipping and handling costs relating to outbound freight are reported as selling, general and
administrative expenses in the consolidated Statements of Operations. The Company classifies amounts billed to customers for shipping
fees as revenues.
Fair
Value Measurements
The
Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received
for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability
in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value
maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with
three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:
|
●
|
Level
1 — Quoted prices in active markets for identical assets or liabilities.
|
|
|
|
|
●
|
Level
2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar
assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated
by observable market data for substantially the full term of the assets or liabilities.
|
|
|
|
|
●
|
Level
3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value
of the assets or liabilities.
|
The
carrying amounts of financial instruments such as cash, accounts receivable, inventories, and accounts payable and accrued liabilities,
approximate the related fair values due to the short-term maturities of these instruments. The carrying values of notes payable
approximate their fair values due to the fact that the interest rates on these obligations are based on prevailing market interest
rates.
The
fair value of the derivative liabilities of $2,161,000 and $1,332,000 at December 31, 2020 and 2019, respectively, was valued
using Level 2 inputs.
Loss
per Share Calculations
Basic
earnings per share are computed by dividing net income (loss) available to common shareholders by the weighted-average number
of common shares available. Diluted earnings per share is computed by dividing the net income applicable to common shareholders
by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding
if all dilutive potential common shares had been issued using the treasury stock method. Potential common shares are excluded
from the computation when their effect is antidilutive. The dilutive effect of potentially dilutive securities is reflected in
diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the
reporting period.
Options
to acquire 10,002,210 shares of common stock, warrants to acquire 28,283,140 shares of common stock, and 173,780,295 shares of
common stock issuable under convertible note agreements, have been excluded from the calculation of weighted average common shares
outstanding at December 31, 2020, as their effect would have been anti-dilutive. Options to acquire 1,948,300 shares of common
stock, warrants to acquire 18,283,140 shares of common stock, and 37,994,931 shares of common stock issuable under convertible
note agreements, have been excluded from the calculation of weighted average common shares outstanding at December 31, 2019, as
their effect would have been anti-dilutive.
Concentration
Risks
Cash
includes cash on hand and cash in banks and are reported as “Cash” in the consolidated balance sheets. At December
31, 2020 and December 31, 2019, cash includes cash on hand of $289,000 and $12,000, respectively, and cash in banks of $83,000
and $92,000, respectively. The balance of cash on hand is not insured by the Federal Deposit Insurance Corporation. The balance
of cash in banks is insured by the Federal Deposit Insurance Corporation for up to $250,000.
The
Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer
needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact the
Company’s operating results. State and federal government laws could have a material adverse impact on the Company’s
future revenues and results of operations.
The
Company’s products require specific components that currently are available from a limited number of sources. The Company
purchases some of its key products and components from single vendors. During the years ended December 31, 2020 and 2019, its
ballasts, lamps, and reflectors, which comprised the clear majority of the Company’s purchases during those periods, were
each only purchased from one separate vendor.
The
Company performs a regular review of customer activity and associated credit risks and does not require collateral or other arrangements.
There were no customers that accounted for more than 10% of the Company’s revenue for the years ended December 31, 2020
and 2019. Shipments to customers outside the United States comprised less than 5% of our sales for the years ended December 31,
2020 and 2019, respectively.
As
of December 31, 2020, three customers accounted for 37%, 23%, and 15% of the Company’s trade accounts receivable balance,
and as of December 31, 2019, two customers accounted for 24% and 10% of the Company’s trade accounts receivable balance.
Segment
Reporting
The
Company operates in one segment for the manufacture and distribution of our products. In accordance with the “Segment Reporting”
Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President,
who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing
guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information
quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which
the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment
Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services;
and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information
required by “Segment Reporting” can be found in the accompanying consolidated financial statements.
Recently
Issued Accounting Pronouncements
In
June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-13, Measurement of Credit Losses on
Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses
(“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may
result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023,
and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification
improvements will be material to its financial position, results of operations and cash flows.
In
August 2020, the FASB issued ASU No. 2020-06 (“ASU 2020-06”) “Debt—Debt with Conversion and Other Options
(Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible
Instruments and Contracts in an Entity’s Own Equity.” ASU 2020-06 will simplify the accounting for convertible
instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting
the accounting models will result in fewer embedded conversion features being separately recognized from the host contract as
compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded
conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and
that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial
premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope
exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06
will be effective for the Company beginning January 1, 2024. Early adoption is permitted, but no earlier than January 1, 2021,
including interim periods within that year. Management is currently evaluating the effect of the adoption of ASU 2020-06 on the
consolidated financial statements, but currently does not believe ASU 2020-06 will have a significant impact on the Company’s
accounting for its convertible debt instruments. The effect will largely depend on the composition and terms of the financial
instruments at the time of adoption.
Other
recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public
Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on
the Company’s present or future financial statements.
NOTE
2 - PROPERTY AND EQUIPMENT
Property
and equipment consist of the following at December 31, 2020 and 2019:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Machinery and equipment
|
|
$
|
67,000
|
|
|
$
|
81,000
|
|
Computer equipment
|
|
|
11,000
|
|
|
|
11,000
|
|
Furniture and
fixtures
|
|
|
40,000
|
|
|
|
40,000
|
|
|
|
|
118,000
|
|
|
|
132,000
|
|
Less: accumulated
depreciation and amortization
|
|
|
(103,000
|
)
|
|
|
(110,000
|
)
|
Property and
equipment, net
|
|
$
|
15,000
|
|
|
$
|
22,000
|
|
Depreciation
expense for the years ended December 31, 2020 and 2019 was $7,000 and $33,000, respectively.
During
the year ended December 31, 2020, the Company disposed of fully depreciated property and equipment of $14,000. During the year
ended December 31, 2019, the Company disposed of property and equipment with a book value of $7,000, resulting in a loss on the
disposal of property and equipment of $7,000.
In
February 2019, the Company terminated its Arizona facility lease thereby abandoning of leasehold improvements with a remaining
unamortized balance of $217,000. The Company recorded the abandonment of leasehold improvements of $217,000 during the year ended
December 31, 2019 as a component of operating expense in the consolidated statement of operations (see Note 5).
NOTE
3 – CONTRACT OBLIGATION ACQUIRED FROM RELATED PARTIES
In
May 2018, the Company entered into an acquisition agreement with the members, which in the aggregate, owned 100% of the membership
interests in YLK, a related party. The major asset of YLK is a Cultivation Management Services Agreement (the “Management
Agreement”) with an Arizona licensee that was entered into on January 5, 2018. During the year ended December 31, 2019,
the Company determined the acquired assets were fully impaired, and recorded an impairment charge of $1,139,000 accordingly. The
Company has a continuing obligation under the Management Agreement of $799,000 (net of discount of $51,000) as of December 31,
2019. As of December 31, 2020, the remaining Management Agreement obligation was $816,000 (net of discount of $34,000) and is
reflected as a current liability in the accompanying consolidated balance sheet. As of December 31, 2020, the Company is past
due on its installment payments obligations under the Management Agreement.
NOTE
4 – NOTES PAYABLE TO RELATED PARTIES – PAST DUE
Notes
payable to related parties consists of the following at December 31, 2020 and 2019:
|
|
December
31, 2020
|
|
|
December
31, 2019
|
|
|
|
|
|
|
|
|
Notes payable to officers/shareholders
– past due (a)
|
|
|
600,000
|
|
|
|
600,000
|
|
Notes payable to related party –
past due (b)
|
|
|
150,000
|
|
|
|
150,000
|
|
Notes payable
to related parties – past due (c)
|
|
|
40,000
|
|
|
|
40,000
|
|
Total
|
|
$
|
790,000
|
|
|
$
|
790,000
|
|
|
a.
|
On
May 9, 2016, the Company entered into note payable agreements with Alan Lien and Alvin Hao, each a former officer and director,
to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, the Company borrowed $300,000
from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or
before May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at December 31, 2020
and 2019.
|
|
|
|
|
b.
|
On
May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow
$150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and is due on November 8, 2019. The note
is currently past due. A total of $150,000 was due on the loans as of December 31, 2020 and 2019.
|
|
|
|
|
c.
|
The
Company entered into note agreements with the parents of Alan Lien, the Company’s Chief Executive Officer and one of
its directors. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The
loans are currently past due. A total of $40,000 was due on the loans as of December 31, 2020 and 2019.
|
At
December 31, 2019, accrued interest on the notes payable to related parties was $149,000. During the year ended December 31, 2020,
the Company added $70,000 of additional accrued interest, and made interest payments of $32,000, leaving an accrued interest on
the notes payable to related parties balance of $187,000 at December 31, 2020.
NOTE
5 – LEASE PAYABLE
In
2019, our principal executive offices and warehouse were located at 853 Sandhill Avenue, Carson, California, 90746. We occupied
a 17,640 square foot facility pursuant to a five-year lease with an independent party ending on June 30, 2023, pursuant to which
we paid $15,000 per month in rental charges. On December 31, 2019, we abandoned our Carson, California lease. The Company remains
obligated under its Carson, California lease, until such time the landlord releases us from our lease agreement. Based on the
abandonment, the Company determined its ROU asset was impaired and recorded an impairment charge of $100,000 during the year ended
December 31, 2019. During the year ended December 31, 2020, management determined it no longer had access to the Carson, California
facility, and recorded an impairment charge for the remaining ROU asset balance of $427,000, which was charged to operating expenses
in the consolidated statements of operations for the year ended December 31, 2020. As of the date of this report, the Company
has not been released from the lease agreement, and no lease payments were made during the year ended December 31, 2020. The remaining
balance of the lease obligation was $556,000 at both December 31, 2020 and 2019.
On
January 1, 2020, the Company relocated its principal executive offices and warehouse to 1689-A Arrow Rt., Upland, California,
91786. The Upland, California lease is for a 2,974 square foot facility pursuant to a three-year lease with an independent party
ending on January 31, 2023, pursuant to which it pays $2,800 per month in rental charges. On January 1, 2020, the Company recognized
an operating lease ROU asset and lease liability of $89,000, related to the Upland, California operating lease. During the year
ended December 31, 2020, the Company reflected amortization of the ROU assets of $26,000 related to its Upland, California operating
lease, resulting in an ROU asset balance of $63,000 as of December 31, 2020.
As
of December 31, 2019, liabilities recorded under operating leases were $556,000. During the year ended December 31, 2020, the
Company added $89,000 in lease liabilities related to its Upland, California operating lease, and made lease payments of $23,000
towards its operating lease liability. As of December 31, 2020, liabilities under operating leases amounted to $622,000, of which
$440,000 were reflected as current due.
The
lease agreements above have a weighted average remaining lease term of 3.50 years as of December 31, 2020. Leases with an initial
term of 12 months or less are not recorded on the balance sheet. The Company accounts for the lease and non-lease components of
its leases as a single lease component. Rent expense is recognized on a straight-line basis over the lease term.
Operating
lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease
term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation
to make lease payments arising from the lease. Generally, the implicit rate of interest in arrangements is not readily determinable
and the Company utilizes its incremental borrowing rate in determining the present value of lease payments. The Company’s
incremental borrowing rate is a hypothetical rate based on its understanding of what its credit rating would be. The operating
lease ROU asset includes any lease payments made and excludes lease incentives.
The
components of rent expense and supplemental cash flow information related to leases for the period are as follows:
|
|
Year
ended
December
31, 2020
|
|
Lease Cost
|
|
|
|
|
Operating lease cost (included
in general and administration in the Company’s statement of operations)
|
|
$
|
36,000
|
|
|
|
|
|
|
Other Information
|
|
|
|
|
Cash paid for amounts included in the
measurement of lease liabilities during the year ended December 31, 2020
|
|
$
|
-
|
|
Weighted average remaining lease term
– operating leases (in years)
|
|
|
3.50
|
|
Average discount rate – operating
leases
|
|
|
10.0
|
%
|
The
supplemental balance sheet information related to leases for the period is as follows:
|
|
At
December 31, 2020
|
|
Operating
leases
|
|
|
|
|
ROU
assets, net of accumulated amortization of $144,000 and an impairment charge of $527,000
|
|
$
|
36,000
|
|
|
|
|
|
|
Current operating lease liabilities
|
|
$
|
440,000
|
|
Long-term operating
lease liabilities
|
|
|
182,000
|
|
Total operating
lease liabilities
|
|
$
|
622,000
|
|
Maturities
of the Company’s lease liabilities are as follows:
Year
Ending
|
|
Operating
Leases
|
|
2021
|
|
$
|
406,000
|
|
2022
|
|
|
225,000
|
|
2023
|
|
|
97,000
|
|
2024
|
|
|
6,000
|
|
2025
|
|
|
-
|
|
Total lease payments
|
|
|
734,000
|
|
Less:
Imputed interest
|
|
|
(112,000
|
)
|
Total operating
lease liability
|
|
|
622,000
|
|
Current
portion
|
|
|
(440,000
|
)
|
|
|
$
|
182,000
|
|
Rent
expense for the twelve months ended December 31, 2020 and 2019 was $36,000 and $316,000, respectively.
NOTE
6 – LEGAL OBLIGATIONS PAYABLE
Lease
Abandonment Settlement
On
February 15, 2019, MSCP, L.L.C (“MSCP”), filed suit in the Superior Court of Arizona, County of Maricopa, Case No.
CV2019-001613 against the Company and YLK. The case arises from YLK’s alleged breach of a certain lease agreement dated
May 19, 2018 (the “Lease”), for the lease of certain real property located at 4301 W. Buckeye Road, Phoenix, Arizona
85043 (the “Premises”), between MSCP and YLK, which the Company guaranteed. MSCP filed the lawsuit after YLK provided
a notice of termination for, amongst other reasons, MSCP’s failure to disclose various material information regarding code,
safety, structural and other issues in the Premises that rendered the Premises unsuitable for use, unless the Company undertook
significant and extraneous costs that were not contemplated under the Lease to remedy said issues in and outside of the Premises.
MSCP’s complaint alleged counts for breach of lease and waste and breach of guaranty. MSCP is seeking compensatory damages,
rents and other charges due under the lease, and attorney’s fees and costs. The Company just recently filed its answer denying
the allegations as well as having filed counterclaims for fraud in the inducement, negligent misrepresentation, breach of the
implied covenant of good faith and fair dealing, rescission of contract, unjust enrichment and punitive damages. On December 12,
2019, MSCP was awarded a default judgment against the Company in the amount of $1,487,000, which is recorded as a charge to operating
expenses in the consolidated statements of operations for the year ended December 31, 2019. During the year ended December 31,
2020, interest of $147,000 was added, leaving a balance owed of $1,634,000, for which the Company negotiated a settlement for
a total consideration of $193,000 and recorded a gain on the settlement of legal obligations of $1,441,000. The $193,000 settlement
payments were comprised of $150,000 in cash, and the issuance of 3,333,333 shares of the Company’s common stock valued at
$43,000.
Employment
Matter Judgment
On
or about June 25, 2018, Matthew Geschke (the “Plaintiff”) filed a breach of contract case against the Company in the
San Diego Superior Court of San Diego, California. The Plaintiff claimed damages for breach of an employment contract when the
Company terminated the Plaintiff’s employment agreement on February 22, 2018. On June 26, 2020, the Plaintiff was awarded
a default judgment against the Company in the amount of $448,000. No payments were made during the year ended December 31, 2020.
On
September 27, 2019, Dennis Forchic (the “Plaintiff”) filed a breach of contract case against the Company in the Los
Angeles Superior Court of Los Angeles, California, under case number 19STCV34592, alleging that the Company wrongfully terminated
the Plaintiff’s employment agreement on February 5, 2018. The Plaintiff claims damages of $646,000 for unpaid severance,
unpaid reimbursed expenses, and unpaid health benefits. In addition, the Plaintiff claims damages for failing to compensate Plaintiff
for 3,000,000 stock options which vested on termination. As of December 31, 2018, the Company had recorded $588,000 related to
this matter. On March 3, 2020, the Plaintiff was awarded a judgment against the Company in the amount of $646,000, plus post judgment
interest, as well as the vesting of options to purchase 1,000,000 shares of the Company’s common stock. During the year
ended December 31, 2019, the Company recorded an additional $58,000 of legal expenses, leaving a total balance due to Plaintiff
of $646,000 at December 31, 2019. During the year ended December 31, 2020, interest of $38,000 was added, leaving a balance owed
of $684,000, for which the Company negotiated a settlement for a total cash consideration of $165,000 and recorded a gain on the
settlement of legal obligations of $519,000.
Breach
of Contract
On
September 12, 2019, DPA, Inc., or DPA, filed suit in the Superior Court of Arizona, County of Maricopa, Case No. CV2019-008265
against us. The plaintiff alleges the Company breached an agreement to pay DPA for architectural design services related to a
facility in Arizona and has requested a judgment for $252,000 plus interest. On September 18, 2019, the DPA was awarded a judgment
against the Company for $252,000 plus interest at 18% per annum from June 6, 2019 until paid. During the year ended December 31,
2019, interest of $22,000 was added, leaving a balance owed of $274,000 at December 31, 2019. During the year ended December 31,
2020, interest of $26,000 was added, leaving a balance owed of $300,000, for which the Company negotiated a settlement for a total
consideration of $37,000 and recorded a gain on the settlement of legal obligations of $263,000. The $37,000 settlement payments
were comprised of $20,000 in cash, and the issuance of 1,000,000 shares of the Company’s common stock valued at $17,000.
On
August 7, 2019, Rose Law Group PC (“RLG”) filed a breach of contract case against the Company in the Superior Court
of the State of Arizona, County of Maricopa, Case No. CV2019-008484 against the Company. RLG alleges breach of a contract to pay
RLG for legal representation, and requested a judgment for $144,000. On October 17, 2019, RLG was awarded judgment against the
Company for $150,000 plus interest at 12% per annum until paid. During the year ended December 31, 2020, additional settlement-related
expenses of $7,000, and interest of $12,000 was added, leaving a balance owed of $162,000, for which the Company negotiated a
settlement for a total cash consideration of $15,000 and recorded a gain on the settlement of legal obligations of $147,000.
NOTE
7 – LOANS PAYABLE
Notes
payable consists of the following at December 31, 2020 and December 31, 2019:
|
|
December
31, 2020
|
|
|
December
31, 2019
|
|
|
|
|
|
|
|
|
Notes payable to Celtic
Bank – past due (a)
|
|
$
|
11,000
|
|
|
$
|
64,000
|
|
SBA Paycheck Protection Program loan
(b)
|
|
|
205,000
|
|
|
|
-
|
|
SBA Economic
Injury Disaster Loan (c)
|
|
|
150,000
|
|
|
|
-
|
|
Total loans payable
|
|
|
366,000
|
|
|
|
64,000
|
|
Loans payable,
current portion
|
|
|
(11,000
|
)
|
|
|
(64,000
|
)
|
Loans payable,
net of current portion
|
|
$
|
355,000
|
|
|
$
|
-
|
|
|
a)
|
On
May 21, 2019, the Company entered into a loan agreement with Celtic Bank in the principal amount of $150,000 with interest
at 40.44% per annum and due on May 21, 2020. The loan was guaranteed by Alvin Hao, a former officer of the Company. A total
of $64,000 was owed on the loan as of December 31, 2019. During the year ended December 31, 2020, the Company made principal
payments of $53,000, leaving a total of $11,000 owed on the loan as of December 31, 2020, and was past due. In February 2021,
the loan was paid in full.
|
|
|
|
|
b)
|
On
May 7, 2020, the Company was granted a loan (the “PPP loan”) from Wells Fargo Bank in the aggregate amount of
$205,000, pursuant to the Paycheck Protection Program (the “PPP”) under the CARES Act.
|
|
|
|
|
|
The
PPP loan agreement is dated May 8, 2020, matures on May 7, 2022, bears interest at a rate of 1% per annum, with the first
six months of interest deferred, and is unsecured and guaranteed by the U.S. Small Business Administration (“SBA”).
The loan term may be extended to May 7, 2025, if mutually agreed to by the Company and lender. The Company applied ASC 470,
Debt, to account for the PPP loan. The PPP loan may be prepaid at any time prior to maturity with no prepayment penalties.
Funds from the PPP loan may only be used for qualifying expenses as described in the CARES Act, including qualifying payroll
costs, qualifying group health care benefits, qualifying rent and debt obligations, and qualifying utilities. The Company
intends to use the entire loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the loan may
be forgiven if they are used for qualifying expenses. The Company intends to apply for forgiveness of the PPP loan with respect
to these qualifying expenses, however, it cannot assure that such forgiveness of any portion of the PPP loan will occur. As
for the potential loan forgiveness, once the PPP loan is, in part or wholly, forgiven and a legal release is received, the
liability would be reduced by the amount forgiven and a gain on extinguishment would be recorded. The terms of the PPP loan
provide for customary events of default including, among other things, payment defaults, breach of representations and warranties,
and insolvency events. The Company was in compliance with the terms of the PPP loan as of December 31, 2020.
|
|
c)
|
On
June 7, 2020, the Company obtained an Economic Injury Disaster Loan (“EIDL”) from the SBA in the amount of $150,000.
Interest on the loan is at the rate of 3.75% per year, and all loan payments are deferred for twelve months, at which time
the balance is payable in monthly installments of $731 over a 30-year term. The loan is secured by all the Company’s
assets. The Company was in compliance with the terms of the EIDL as of December 31, 2020.
|
NOTE
8 – CONVERTIBLE SECURED NOTE PAYABLE TO RELATED PARTY
Secured
notes payable to related party consists of the following as of December 31, 2020 and December 31, 2019:
|
|
December
31, 2020
|
|
|
December
31, 2019
|
|
|
|
|
|
|
|
|
YA II PN, Ltd.
|
|
$
|
2,275,000
|
|
|
$
|
1,775,000
|
|
Less debt discount
|
|
|
(220,000
|
)
|
|
|
(178,000
|
)
|
Secured note
payable, net
|
|
$
|
2,055,000
|
|
|
$
|
1,597,000
|
|
On
May 10, 2018 and October 29, 2019, the Company issued convertible secured debentures (“Notes”) to YA II PN Ltd. (“YA
II PN”) in the principal amounts of $1,500,000 and $275,000, respectively, with interest rates of 8% and 10%, respectively,
which matured in June 2020 and April 2020, respectively. The notes are currently past due. The Company is in discussion with YA
II PN to extend the maturity date of the Notes. The Notes provide a conversion right, in which the principal amount of the Note,
together with any accrued but unpaid interest, could be converted into the Company’s common stock at a conversion price
at 75% of the lowest volume weighted average price (VWAP) of the Company’s Common Stock during the 10 trading days immediately
preceding the conversion date. As part of the issuance, the Company also granted YA II PN 5-year warrants, which were modified,
to purchase a total of 13,000,000 shares of the Company at an exercise price of $0.05 per share, with expiration dates ranging
from May 2024 to December 2024.
During
the year ended December 31, 2019, the Company twice entered into an amendment agreement with YA II, PN, which amended the secured
promissory note in the principal face amount of $1.5 million issued on May 10, 2018 (the “Note”). The maturity date
of the Note was first extended to August 9, 2019 and then to June 30, 2020. Furthermore, the Note was first amended to be converted
into the Company’s common stock at a conversion price of $0.50 a share, as the Note was not convertible previously, and
the Note was further amended to provide a conversion right, in which the principal amount of the Note, together with any accrued
but unpaid interest, could be converted into the Company’s common stock at a conversion price at 75% of the lowest volume
weighted average price (VWAP) of the Company Common Stock during the 10 trading days immediately preceding the conversion date.
The Company calculated the fair market value of the Secured Note Payable before and after the modifications above and recorded
the difference of $962,000 as a debt extinguishment cost and included in other expenses during the twelve months ended December
31, 2019.
The
7,500,000 warrants granted as part of the Note issuances were also twice modified to ultimately change the exercise price from
$0.50 per share (1,000,000 warrants), $0.75 per share (2,250,000 warrants), $1.00 per share (2,250,000 warrants) and $1.25 per
share (2,000,000 warrants) to $0.05 per share for all four warrants. Furthermore, the amendments removed the Company’s right
of redemption and right to compel exercise on certain Warrants. The Company calculated the fair market value of the Warrants before
and after the modifications above and recorded the difference of $194,000 as a financing cost included in other expenses during
the twelve months ended December 31, 2019.
On
February 13, 2020, the Company issued a note (the “2020 Note”) to YAII PN in the amount of $150,000. The 2020 Note
bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021. The Company received net
proceeds of $125,000, net of closing costs of $25,000. The 2020 Note is secured by all the assets of the Company and its subsidiaries.
The 2020 Note provides a conversion right, in which any portion of the principal amount of the 2020 Note, together with any accrued
but unpaid interest, may be converted into the Company’s common stock at a conversion price equal to 75% of the lowest VWAP
of the Company’s common stock during the ten (10) trading days immediately preceding the date of conversion, subject to
adjustment. As such, the Company determined that the conversion feature created a derivative with a fair value of $109,000 at
the date of issuance. The Company also granted YA II PN 5-year warrants with a fair value of $66,000, to purchase a total of 3,000,000
shares of the Company at an exercise price of $0.05 per common share. The aggregate amount of the closing costs, and the fair
value of the derivative liability, was $177,000, of which $150,000 was recorded as a valuation discount on the 2020 Note to be
amortized over the life of the 2020 Note, and $27,000 was recorded as a financing cost during the year ended December 31, 2020.
On
September 23, 2020, the Company issued a note (the “September 2020 Note”) to YAII PN in the amount of $350,000. The
September 2020 Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of March 23, 2021. The
Company received net proceeds of $340,000, net of closing costs of $10,000. The September 2020 Note is secured by all the assets
of the Company and its subsidiaries. The September 2020 Note provides a conversion right, in which any portion of the principal
amount of the September 2020 Note, together with any accrued but unpaid interest, may be converted into the Company’s common
stock at a conversion price equal to 75% of the lowest VWAP of the Company’s common stock during the ten (10) trading days
immediately preceding the date of conversion, subject to adjustment. As such, the Company determined that the conversion feature
created a derivative with a fair value of $322,000 at the date of issuance. The Company also granted YA II PN 5-year warrants
with a fair value of $68,000, to purchase a total of 7,000,000 shares of the Company at an exercise price of $0.05 per common
share. The aggregate amount of the closing costs, and the fair value of the warrants and derivative liability, was $389,000, of
which $350,000 was recorded as a valuation discount on the September 2020 Note to be amortized over the life of the September
2020 Note, and $39,000 was recorded as a financing cost during the year ended December 31, 2020.
During
the year ended December 31, 2019, amortization of valuation discount was $89,000 and was recorded as an interest cost, leaving
a $178,000 remaining unamortized balance of the valuation discount at December 31, 2019. During the year ended December 31, 2020,
valuation discounts of $500,000 were added as discussed above, and amortization of valuation discount of $458,000 was recorded
as an interest cost, leaving a $220,000 remaining unamortized balance of the valuation discount at December 31, 2020.
At
December 31, 2019, accrued interest on the convertible secured notes payable to related parties of $202,000 was included in accrued
interest to related parties on the consolidated balance sheet. During the year ended December 31, 2020, interest of $29,000 was
converted into common stock (see Note 11), and the Company added $171,000 of additional accrued interest, leaving an accrued interest
to related parties balance of $344,000 at December 31, 2020.
As
of December 31, 2020, 239,274,957 shares of common stock were potentially issuable under the conversion terms of the convertible
secured notes.
NOTE
9 – ACQUISITION OF FACILITY, LOAN AGREEMENT, AND SUBSEQUENT SETTLEMENT
Acquisition
of Facility
On
April 2, 2019, the Company, through its wholly-owned subsidiary Extracting Point, entered into an agreement to purchase real property
located at 2601 West Holly Street in Phoenix, Arizona (the “Property”) for $3,500,000. The Property held the approval
and authorization for a Conditional Use Permit, which allowed the Property to be used for the operation of a cultivation and infusion
facility, allowing for the cultivation, harvesting, preparation, packaging and storing of medical cannabis, as well as extraction,
refinement, infusion, production, preparation, packaging, and storage of manufactured and derivative oils, waxes, concentrates,
edible and non-edible products that contain cannabis.
Loan
Agreement
On
April 2, 2019, Extracting Point entered into a loan agreement (the “Loan Agreement”) with Michael Cannon and Jennifer
Cannon, Trustees of the Core 4 Trust Dated February 29, 2016 (the “Lender”), pursuant to which Extracting Point borrowed
$3,500,000 from the Lender (the “Loan”). The Loan was evidenced by an installment note – interest included (the
“Note”), guaranteed by the Company pursuant to a corporate guaranty (the “Guaranty”) and was secured by
a first priority lien on the Property pursuant to a deed of trust and assignment of rents between Extracting Point and Thomas
Title & Escrow, for the benefit of the Lender (the “Deed of Trust”). Extracting Point used the net proceeds from
the Loan to acquire the Property.
The
Note, together with accrued and unpaid interest, was due and payable on March 31, 2024 (the “Maturity Date”). Interest
on the Note was to accrue at the rate of 10% per annum. For the first 12 months, Extracting Point was to pay the Lender interest
only of $29,167 per month. After the first 12 months, Extracting Point was to pay the Lender principal and interest of $88,769
per month. Extracting Point had the right to prepay the Note at any time, however, Extracting Point agreed to pay the first 36
months of interest, even if the Note was repaid prior to that date.
As
additional consideration for the issuance of the Loan, Extracting Point and the Company agreed to pay the Lender an amount equal
to five percent (5%) of the management fees (the “Management Royalty”) received relating to the services rendered
on the Property, for a period of three years from the date an “Approval to Operate” is granted by the Arizona Department
of Health Services (such date, the “Commencement Date”). In the event that the Commencement Date has not occurred
on or prior to April 2, 2021, then Extracting Point and the Company agreed to pay the Lender an amount equal to five percent (5%)
of the fair market value of the rent of the Property as if the Property was fully occupied (the “Rental Royalty”),
such payments to be made each month for a period of thirty-nine months, provided, that, if the Commencement Date occurs after
the Rental Royalty has commenced, the Rental Royalty payments shall cease and the Management Royalty payments shall commence,
and any amounts paid as a Rental Royalty shall be credited against any Management Royalty owed.
In
connection with the Loan, the Company issued to the Lender a warrant (the “Warrant”) to purchase 1,000,000 shares
of the Company’s common stock, exercisable for five years from issuance at an exercise price of $1.00 per share. The Warrant
exercise price is subject to adjustment only in the event of a stock dividend or split.
Extracting
Point was delinquent in payment under the Note, and the Lender informed Extracting Point and the Company that unless payment was
made current or an agreement reached between the parties, the Lender would declare Extracting Point in default, call the entire
Note due and payable, record a notice of default of the Deed of Trust, and take any other actions it deemed necessary or appropriate
against the Company and Extracting Point.
Settlement
Agreement
On
May 24, 2019, the Company and Extracting Point entered into a Deed in Lieu of Foreclosure Release and Settlement Agreement (the
“Settlement Agreement”) with the Lender. Pursuant to the Settlement Agreement, Extracting Point executed a Deed in
Lieu of Foreclosure (the “Deed”), conveying the real property located at 2601 West Holly Street in Phoenix, Arizona
to the Lender.
In
exchange, the Lender agreed to release the Company and Extracting Point from all their obligations under the Loan Agreement, the
Note, the Deed of Trust and the Guaranty. Pursuant to the Settlement Agreement, the Loan Agreement, the Note, the Deed of Trust
and the Guaranty were terminated. In addition, the Warrant was returned to the Company and canceled.
NOTE
10 – DERIVATIVE LIABILITY
The
FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative
instruments. The conversion prices and the exercise prices of the notes as described in Note 8 were not a fixed amount because
they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the
number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available
to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features of the notes have
been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported
in the statement of operations.
As
of December 31, 2020, and 2019, the derivative liabilities were valued using either a probability weighted average Monte Carlo
pricing model or the Black Scholes pricing model with the following assumptions:
|
|
At
December 31, 2020
|
|
|
Issued
During 2020
|
|
|
At
December 31, 2019
|
|
|
Issued
During 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise Price
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
Stock Price
|
|
$
|
0.013
|
|
|
$
|
0.011
– 0.025
|
|
|
$
|
0.01
|
|
|
$
|
0.02
|
|
Risk-free interest rate
|
|
|
0.09
|
%
|
|
|
0.11
– 1.48
|
%
|
|
|
1.55
– 1.60
|
%
|
|
|
1.64
|
%
|
Expected volatility
|
|
|
268
– 278
|
%
|
|
|
233
– 324
|
%
|
|
|
201
– 203
|
%
|
|
|
147-165
|
%
|
Expected life (in years)
|
|
|
0.25
– 0.62
|
|
|
|
0.50
– 1.50
|
|
|
|
0.33
– 0.50
|
|
|
|
.050-0.67
|
%
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
%
|
|
|
0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion
feature
|
|
$
|
2,161,000
|
|
|
$
|
431,000
|
|
|
$
|
1,332,000
|
|
|
$
|
1,129,000
|
|
The
risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility
of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the
notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not
customarily paid dividends in the past and does not expect to pay dividends in the future.
The
balance of the derivative liability at December 31, 2019 was $1,332,000. During the year ended December 31, 2020, the Company
recognized derivative liabilities of $431,000 upon issuance of a secured convertible notes (see Note 8), and recognized $398,000
as other expense, which represented the change in the fair value of the derivative from the respective prior period, leaving a
$2,161,000 balance of the derivative liability at December 31, 2020.
During
the prior years, the Company issued 7,950,000 warrants as part of its Convertible Notes and Series A preferred stock financings.
The Company determined that the exercises prices of the warrants were not a fixed amount because they were subject to an adjustment
based on the occurrence of future offerings or events. As a result, the Company had determined at issuance that the warrants should
be classified as liabilities due to variability in shares to be issued and changes in exercise price due to down round protection.
The fair value of these liabilities at December 31, 2018 was $2,161,000. During the year ended December 31, 2019, the Company
adopted ASU 2017-11, which simplified the accounting for financial instruments with down round features. The adoption resulted
in the reclassification of the Company’s derivative liability to equity of $2,161,000 as of January 1, 2019.
During
the year ended December 31, 2019, the Company recognized derivative liabilities of $167,000 upon issuance of a secured convertible
note (see Note 8), and recognized $203,000 as other expense, which represented the change in the fair value of the derivative
from the respective prior period. In addition, the Company recognized a derivative liability of $962,000 that resulted from a
change in the terms of two convertible notes that was recorded as a financing cost and included in other expense. The balance
of the derivative liability at December 31, 2019 was $1,332,000.
NOTE
11 – SHAREHOLDERS’ EQUITY
Common
Shares Issued on Conversion of Convertible Note Payable
During
the year ended December 31, 2020, the Company was notified by YA II PN (see Note 8) in writing of their election to convert $29,000
of interest accrued on convertible notes payable into 2,287,066 shares of the Company’s common at a conversion price of
$0.0127 per share. As the closing trading price on date of conversion was $0.05 per share, the fair market value of the shares
issued on conversion of interest was $114,000. The Company recorded a loss on extinguishment of accrued interest of $85,000, which
represents the difference between the fair market value of the shares issued of $114,000, and the carrying value of the accrued
interest of $29,000, which is included as a component of other expense on the consolidated statements of operations for the year
ended December 31, 2020.
Common
Shares Issued to Directors
The
Company appointed certain directors and issued shares as part of their director compensation agreements. During the years ended
December 31, 2020 and 2019, the Company issued an aggregate of 6,116,867 and 600,000 shares of common stock, with a fair value
of $92,000 and $78,000 at date of grant, respectively, which was recognized as compensation cost.
Common
Shares Issued for Services
The
Company entered into various consulting agreements with third parties (“Consultants”) pursuant to which these Consultants
provided business development, sales promotion, introduction to new business opportunities, strategic analysis and sales and marketing
activities. No shares for services were issued for the year ended December 31, 2020. During the year ended December 31, 2019,
the Company issued an aggregate of 426,000 shares of common stock to these consultants, with a fair value of $178,000 at date
of grant.
Common
Shares Issued for Legal Judgments
During
the year ended December 31, 2020, the Company issued an aggregate of 4,333,333 shares of common stock, with a fair value of $60,000
at the date of grant, as settlement of certain legal judgments (see Note 6).
2018
Stock Incentive Plan
On
November 30, 2018, the 2018 Stock Incentive Plan (the “Plan”) for officers, employees, non-employee members of the
Board of Directors, and consultants of the Company was approved pursuant to a Joint Written Consent of the Board of Directors
and Majority Stockholders of the Company. The Plan authorized the granting of not more than 10,000,000 restricted shares, stock
appreciation rights (“SAR’s”), and incentive and non-qualified stock options to purchase shares of the Company’s
common stock. The Plan provided that stock options or SAR’s granted can be exercisable immediately as of the effective date
of the applicable agreement, or in accordance with a schedule or performance criteria as may be set in the applicable agreement.
The exercise price for non-qualified stock options or SAR’s would be the amount specified in the agreement, but shall not
be less than the fair value of the Company’s common stock at the date of the grant. The maximum term of options and SARs
granted under the plan is ten years. During the years ended December 31, 2020 and 2019, the Company issued 8,068,910 and 833,300
options to purchase shares of its common stock under the Plan, and 15,000 and 7,279,391 were forfeited, respectively. As of December
31, 2020, options to purchase 2,920,867 shares of common stock remain reserved for issuance under the Plan.
Summary
of Stock Options
A
summary of stock options for the years ended December 31, 2020 and 2019, is as follows:
|
|
|
|
|
Weighted
|
|
|
|
Number
|
|
|
Average
|
|
|
|
of
|
|
|
Exercise
|
|
|
|
Options
|
|
|
Price
|
|
Balance outstanding,
December 31, 2018
|
|
|
8,394,391
|
|
|
|
0.66
|
|
Options granted
|
|
|
833,300
|
|
|
|
0.03
|
|
Option exercised
|
|
|
-
|
|
|
|
-
|
|
Options expired
or forfeited
|
|
|
(7,279,391
|
)
|
|
|
(0.67
|
)
|
Balance outstanding, December 31,
2019
|
|
|
1,948,300
|
|
|
|
0.35
|
|
Options granted
|
|
|
8,068,910
|
|
|
|
0.012
|
|
Options exercised
|
|
|
-
|
|
|
|
-
|
|
Options expired
or forfeited
|
|
|
(15,000
|
)
|
|
|
(0.69
|
)
|
Balance outstanding,
December 31, 2020
|
|
|
10,002,210
|
|
|
$
|
0.077
|
|
Balance exercisable,
December 31, 2020
|
|
|
10,002,210
|
|
|
$
|
0.077
|
|
Executive
Employment Agreement
On
October 31, 2019, the Board of Directors of the Company reappointed Ms. Tiffany Davis as Chief Executive Officer, Chief Financial
Officer and as a director, effective immediately. In connection with the appointment of Ms. Davis, the Company granted her options
to purchase 833,300 shares of common stock, which vested immediately, expire five years from the date of issuance, and are exercisable
at a price of $0.03 per share. The fair value of the stock options granted was determined to be $25,000, which was recorded to
stock-based compensation expense during the year ended December 31, 2019. Ms. Davis is entitled to receive stock options of $25,000
of shares per quarter at the then closing market price on the last trading day at the end of each calendar quarter, which expire
five years from the date of issuance. Accordingly, during the year ended December 31, 2020, Ms. Davis was granted a total of 8,068,910
stock options, with the fair value determined to be $93,000, and was recorded to stock-based compensation expense during the year
ended December 31, 2020.
The
fair value of each option on the date of grant was estimated using the Black-Scholes option pricing model with the following weighted
average assumptions:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Exercise Price
|
|
$
|
0.012
|
|
|
$
|
0.03
|
|
Stock Price
|
|
$
|
0.012
|
|
|
$
|
0.03
|
|
Risk-free interest rate
|
|
|
0.21
|
%
|
|
|
1.51
|
%
|
Expected volatility
|
|
|
211
|
%
|
|
|
155
|
%
|
Expected life (in years)
|
|
|
3.0
|
|
|
|
5.0
|
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
Information
relating to outstanding options at December 31, 2020, summarized by exercise price, is as follows:
|
|
|
Outstanding
|
|
|
Exercisable
|
|
Exercise
Price Per Share
|
|
|
Shares
|
|
|
Life
(Years)
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
$
|
0.01-0.03
|
|
|
|
8,902,210
|
|
|
|
5.78
|
|
|
$
|
0.014
|
|
|
|
8,902,210
|
|
|
$
|
0.014
|
|
$
|
0.46
|
|
|
|
100,000
|
|
|
|
3.95
|
|
|
$
|
0.46
|
|
|
|
100,000
|
|
|
$
|
0.46
|
|
$
|
0.60
|
|
|
|
1,000,000
|
|
|
|
2.11
|
|
|
$
|
0.60
|
|
|
|
1,000,000
|
|
|
$
|
0.60
|
|
|
|
|
|
|
10,002,210
|
|
|
|
2.54
|
|
|
$
|
0.077
|
|
|
|
10,002,210
|
|
|
$
|
0.077
|
|
As
of December 31, 2020, the Company has no outstanding unvested options with future compensation costs. In addition, there will
be future compensation related to the options to be awarded to Ms. Davis under her employment agreement discussed above. The weighted-average
remaining contractual life of options outstanding and exercisable at December 31, 2020 was 2.54 years. Both the outstanding and
exercisable stock options had an intrinsic value of $10,000 at December 31, 2020.
Summary
of Warrants
A
summary of warrants for the years ended December 31, 2020 and 2019, is as follows:
|
|
|
|
|
Weighted
|
|
|
|
Number
|
|
|
Average
|
|
|
|
of
|
|
|
Exercise
|
|
|
|
Warrants
|
|
|
Price
|
|
Balance outstanding,
December 31, 2018
|
|
|
12,783,140
|
|
|
$
|
0.91
|
|
Warrants granted
|
|
|
5,500,000
|
|
|
|
0.05
|
|
Warrants exercised
|
|
|
-
|
|
|
|
-
|
|
Warrants expired
or forfeited
|
|
|
-
|
|
|
|
-
|
|
Balance outstanding, December 31,
2019
|
|
|
18,283,140
|
|
|
|
0.06
|
|
Warrants granted
|
|
|
10,000,000
|
|
|
|
0.05
|
|
Warrants exercised
|
|
|
-
|
|
|
|
-
|
|
Warrants expired
or forfeited
|
|
|
-
|
|
|
|
-
|
|
Balance outstanding,
December 31, 2020
|
|
|
28,283,140
|
|
|
$
|
0.05
|
|
Balance exercisable,
December 31, 2020
|
|
|
28,283,140
|
|
|
$
|
0.05
|
|
Information
relating to outstanding warrants at December 31, 2020, summarized by exercise price, is as follows:
|
|
|
Outstanding
|
|
|
Exercisable
|
|
Exercise
Price Per Share
|
|
|
Shares
|
|
|
Life
(Years)
|
|
|
Weighted
Average
Exercise
Price
|
|
|
Shares
|
|
|
Weighted
Average
Exercise
Price
|
|
$
|
0.01
|
|
|
|
5,000,000
|
|
|
|
2.35
|
|
|
$
|
0.01
|
|
|
|
5,000,000
|
|
|
$
|
0.01
|
|
$
|
0.05
|
|
|
|
23,000,000
|
|
|
|
3.66
|
|
|
$
|
0.05
|
|
|
|
23,000,000
|
|
|
$
|
0.05
|
|
$
|
1.10
|
|
|
|
283,140
|
|
|
|
1.80
|
|
|
$
|
1.10
|
|
|
|
283,140
|
|
|
$
|
1.10
|
|
|
|
|
|
|
28,283,140
|
|
|
|
3.41
|
|
|
$
|
0.05
|
|
|
|
28,283,140
|
|
|
$
|
0.05
|
|
During
the years ended December 31, 2020 and 2019, the Company issued five-year warrants with a fair value of $43,000 and $57,000, to
purchase 5,500,000 and 10,000,000 shares of common stock at an exercise price of $0.05 as part of a secured convertible promissory
note, respectively (see Note 8). The weighted-average remaining contractual life of warrants outstanding and exercisable at December
31, 2020 was 3.41 years. Both the outstanding and exercisable warrants had an intrinsic value of $15,000 at December 31, 2020.
The
fair value of each warrant on the date of grant was estimated using the Black-Scholes option pricing model with the following
weighted average assumptions:
|
|
2020
|
|
|
2019
|
|
|
|
|
|
|
|
|
Exercise Price
|
|
$
|
0.05
|
|
|
$
|
0.05
|
|
Stock Price
|
|
$
|
0.016
|
|
|
$
|
0.02
|
|
Risk-free interest rate
|
|
|
0.53
|
%
|
|
|
1.65
|
%
|
Expected volatility
|
|
|
214
|
%
|
|
|
171
|
%
|
Expected life (in years)
|
|
|
3.0
|
|
|
|
3.0
|
|
Expected dividend yield
|
|
|
0
|
%
|
|
|
0
|
%
|
NOTE
12 – COMMITMENTS AND CONTINGENCIES
Technology
License Agreement
The
Company entered into a Technology License Agreement with a third-party vendor for consulting services. Under the agreement, the
Company will pay the vendor a minimum consulting amount of $100,000 per year, plus a royalty of 7% of all net sales of the vendor’s
products above $1,429,000 per calendar year. For each of the years ended December 31, 2020 and 2019, $100,000 was recorded as
research and development expense under the agreement on the consolidated Statements of Operations related to the minimum annual
fee. For each of the years ended December 31, 2020 and 2019, no royalty was recorded as cost of goods sold on the Consolidated
Statements of Operations. A total of $339,000 and $239,000 was owed under the amended agreement at December 31, 2020 and 2019,
respectively.
Litigation
On
September 25, 2018, Matthew Geschke (the “Plaintiff”) filed a breach of contract case against the Company in the San
Diego Superior Court of San Diego, California. The Plaintiff claimed damages of $335,000 for breach of an employment contract
when the Company terminated the Plaintiff’s employment agreement on February 22, 2018. On June 26, 2020, the Plaintiff was
awarded a default judgment against the Company in the amount of $448,000 (see Note 6).
NOTE
13 – INCOME TAXES
At
December 31, 2020, the Company had available Federal and state net operating loss carryforwards to reduce future taxable income.
The amounts available were approximately $14,119,000 for Federal and state purposes. The carryforwards expire in various amounts
through 2040. Given the Company’s history of net operating losses, management has determined that it is more likely than
not that the Company will not be able to realize the tax benefit of the carryforwards. Accordingly, the Company has not recognized
a deferred tax asset for this benefit. Section 382 generally limits the use of NOLs and credits following an ownership change,
which occurs when one or more 5 percent shareholders increase their ownership, in aggregate, by more than 50 percentage points
over the lowest percentage of stock owned by such shareholders at any time during the “testing period” (generally
three years).
Effective
January 1, 2007, the Company adopted FASB guidelines that address the determination of whether tax benefits claimed or expected
to be claimed on a tax return should be recorded in the financial statements. Under this guidance, we may recognize the tax benefit
from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the
taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from
such a position should be measured based on the largest benefit that has a greater than fifty percent likelihood of being realized
upon ultimate settlement. This guidance also provides guidance on de-recognition, classification, interest and penalties on income
taxes, accounting in interim periods and requires increased disclosures. At the date of adoption, and as of December 31, 2020
and 2019, the Company did not have a liability for unrecognized tax benefits, and no adjustment was required at adoption.
The
Company’s policy is to record interest and penalties on uncertain tax provisions as income tax expense. As of December 31,
2020, and 2019, the Company has not accrued interest or penalties related to uncertain tax positions. Additionally, tax years
2017 through 2020 remain open to examination by the major taxing jurisdictions to which the Company is subject.
Upon
the attainment of taxable income by the Company, management will assess the likelihood of realizing the tax benefit associated
with the use of the carryforwards and will recognize the appropriate deferred tax asset at that time.
The
Company’s effective income tax rate differs from the amount computed by applying the federal statutory income tax rate to
loss before income taxes as follows:
|
|
December
31, 2020
|
|
|
December
31, 2019
|
|
|
|
|
|
|
|
|
Income tax benefit at federal
statutory rate
|
|
|
(21.0
|
)%
|
|
|
(21.0
|
)%
|
State income tax benefit, net of federal
benefit
|
|
|
(6.0
|
)%
|
|
|
(6.0
|
)%
|
Change in valuation
allowance
|
|
|
27.00
|
%
|
|
|
27.00
|
%
|
|
|
|
|
|
|
|
|
|
Income taxes
at effective tax rate
|
|
|
-
|
|
|
|
-
|
%
|
The
components of deferred taxes consist of the following at December 31, 2020 and 2019:
|
|
December
31, 2020
|
|
|
December
31, 2019
|
|
|
|
|
|
|
|
|
Inventory reserves
|
|
$
|
95,000
|
|
|
$
|
212,000
|
|
Allowance for doubtful accounts and
returns
|
|
|
100,000
|
|
|
|
9,000
|
|
Depreciation and amortization
|
|
|
(33,000
|
)
|
|
|
(53,000
|
)
|
Net operating loss carryforwards
|
|
|
3,789,000
|
|
|
|
2,721,000
|
|
Less: Valuation
allowance
|
|
|
(3,951,000
|
)
|
|
|
(2,889,000
|
)
|
|
|
|
|
|
|
|
|
|
Net deferred
tax assets
|
|
$
|
-
|
|
|
$
|
-
|
|
NOTE
14 – SUBSEQUENT EVENTS
Chief
Executive Officer
On
January 1, 2021, Company entered into a new five year employment agreement with Tiffany Davis as the Company’s Chief Executive
Officer. As part of the employment agreement, Ms. Davis is entitled to receive stock options of $12,500 per quarter for a five
year period at the then closing market price on the last trading day at the end of each calendar quarter.
Trade
Accounts Payable Balance Settlement and Release
On
March 30, 2021, the Company entered into a Settlement Agreement and Release (“Agreement”) with Sichenzia Ross Ference
LLP (“SRF”), for services that were performed for the Company. The Company owed SRF $160,000, which was included in
accounts payable and accrued expenses on the accompanying balance sheet.
The
Company agreed to pay SRF the sum total of Seventy-Five Thousand Dollars ($75,000) (the “Settlement Payment”). The
Settlement Payment shall be made in fifteen monthly installments to be paid no later than the fifteenth day of each month (the
“Installment Payments”), commencing on March 31, 2021 (the “Initial Installment Payment”), and with the
last Installment Payment due no later than May 31, 2022 (the “Final Payment”). As an alternative to the Settlement
Payment, the Company shall have the option to pay to SRF:
a.
The Initial Installment Payment of $5,000 on or before March 31, 2021, $5,000 on or before April 30, 2021, and a lump sum payment
of $40,000 on or before June 7, 2021, for a total payment of $50,000; or
b.
The Initial Installment Payment of $5,000 on or before March 31, 2021, $5,000 on or before April 30, 2021, $5,000 on or before
May 31, 2021, $5,000 on or before June 30, 2021, $5,000 on or before July 30, 2021 and a lump sum payment of $50,000 on or before
August 6, 2021 for a total payment of $75,000.
As
further consideration of the full and final settlement of these matters, the Company issued to SRF, a cashless five year warrant
to purchase four million (4,000,000) shares of common stock of the Company at an exercise price per share equal to $0.001 per
share.